| Application no. and date | 01937764.7 (espacenet) (Federated) (European Patent Register), 20010523 | | Patent/reg. no. and date | DK/EP 1248802, 20040714 | | Publication date | 20021016 | | Priority no. and date | US 579927, 20000526, US 214065 P, 20000626 | | EP pub. no. and date |
EP 1248802 20021016 | | Effective date | | | Applicant/owner | Bristol-Myers Squibb Co., P.O. Box 4000,
Lawrenceville-Princeton Road
Princeton, NJ 08543-4000, US | | Applicant ref. no. | 120143 | | Inventor | NAEMURA, Joseph, R., 2627 127th Avenue NE
Bellevue, WA 98005, US,
LINSLEY, Peter, S., 2430 9th Avenue W.
Seattle, WA 98119, US,
BAJORATH, Jurgen, 17406 37th Avenue
Lynwood, WA 98037, US,
PEACH, Robert, J., 12848 Via Caballo Rojo
San Diego, CA 92129, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | C07K 14/705 (2006.01) | | Title | Opløselige CTLA4-mutantmolekyler og anvendelser deraf | | Int. application no. | US2001017139 | | Int. publication no. | WO2001092337 | | Related patent (certificate) | CA 2011 00032 | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
